Surgical wound clinical trials
14 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Zinc Oxide Versus Petrolatum Following Skin Surgery
- Regenn® Therapy System Safety Study
- A Prospective, Single-arm, Clinical Trial of Electrospun Fiber Matrix (Restrata) in the Treatment of Surgical Defects Secondary to Resection of Malignant Cutaneous Neoplasms
- Mechanisms Underlying Impaired Diabetic Wound Healing
- Safety and Efficacy of ActiGraft Treatment in Wound Care in Medical Centers
- Aesthetic Outcome of Tie-over Bolster Application in Surgical Wounds
- Outcomes of Running Locking Suture vs Standard Running Suture in Surgical Wounds
- Early Versus Delayed Bathing of Orthopaedic Surgical Wounds
- Efficacy and Safety of Topical Timolol in Secondary Intention Surgical Wounds Healing
- Use of Fish Skin Graft (FSG) to Improve Wound Healing and Expedite Discharge at a County Safety-net Hospital
- BIO-SEE: Bioburden Imaging Outcome Study for Equivalence Evaluation
- Use of Hydroprep Wound Therapy With Motion Negative Pressure Therapy for Treatment of Chronic Lower Extremity Wounds
- Kerecis Real-World Fish Skin Graft Registry
- Dermabrasion in Mohs: Split-Scar Trial
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Surgical wound” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.